News stories about Orthopediatrics (NASDAQ:KIDS) have been trending positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Orthopediatrics earned a daily sentiment score of 0.29 on Accern’s scale. Accern also gave news headlines about the company an impact score of 46.2578730854438 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Several brokerages have recently issued reports on KIDS. Zacks Investment Research lowered Orthopediatrics from a “hold” rating to a “sell” rating in a research note on Tuesday, January 9th. BTIG Research reaffirmed a “buy” rating and set a $24.00 price target on shares of Orthopediatrics in a research note on Friday, January 5th. Finally, BidaskClub lowered Orthopediatrics from a “hold” rating to a “sell” rating in a research note on Tuesday, January 9th. Two analysts have rated the stock with a sell rating and four have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $23.67.
NASDAQ:KIDS opened at $15.06 on Friday. Orthopediatrics has a 1-year low of $14.47 and a 1-year high of $23.00. The company has a debt-to-equity ratio of 0.53, a quick ratio of 5.29 and a current ratio of 7.35.
TRADEMARK VIOLATION WARNING: This report was published by BBNS and is the property of of BBNS. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://baseballnewssource.com/2018/03/30/positive-media-coverage-somewhat-unlikely-to-affect-orthopediatrics-kids-stock-price/1973702.html.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems.
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.